CANNABIDIOL OIL MEDICAL

Brand Owner Address Description
RCANN AKOS BIOSCIENCES, INC. 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 cannabidiol oil for medical and therapeutic purposes; cannabis oil for therapeutic purpose; cannabis oil for the treatment of cancer; medicinal cannabis for the relief of nerve pain, nausea, and muscle spasms; antibiotic ointments; anti-inflammatory ointments; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; transdermal patches for use in the treatment of cancer, for the relief of nerve pain, nausea, sleep and appetite; medicinal cannabis for the aid to sleep; skin ointment to treat radio-dermatitis; cannabis and CBD based oils, creams, ointments, capsules and patches for treatment of medical and therapeutic issues; any CBD in the goods being either synthetic CBD or CBD solely derived from hemp or other natural products, and with a delta-9 tetrahdyrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;cannabidiol skin and body oil for cosmetic purposes; cannabis skin and body oil for cosmetic purposes; bath oil; essential oil for personal use; facial oil; skin cream; aromatic oil; terpenes as essential oil; cannabis and CBD based oils, creams, ointments, capsules and patches for treatment of cosmetic issues; any CBD in the goods being either synthetic CBD or CBD solely derived from hemp or other natural products, and with a delta-9 tetrahdyrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. A method for controlling inventory of a time sensitive medical product includes providing packaging for the medical product, setting an expiration date for the medical product; and displaying the expiration date with the medical product in a visible manner on or within the packaging or on or within the medical product. A warning period is set for warning of an upcoming expiration for the medical product in advance of the expiration date and elapsed time is monitored with the packaging or with the medical product after setting the expiration date for the medical product. A warning indicator is displayed on or within the packaging or on or within the medical product of the upcoming expiration for the medical product upon commencement of the warning period.